首页> 外文期刊>Archives of pharmacal research >The surmountable effect of FSCPX, an irreversible A(1) adenosine receptor antagonist, on the negative inotropic action of A(1) adenosine receptor full agonists in isolated guinea pig left atria.
【24h】

The surmountable effect of FSCPX, an irreversible A(1) adenosine receptor antagonist, on the negative inotropic action of A(1) adenosine receptor full agonists in isolated guinea pig left atria.

机译:FSCPX,一种不可逆转的A(1)腺苷受体拮抗剂的可移动效果,在分离的豚鼠中左侧豚鼠的负激动剂的负异滴度作用。

获取原文
获取原文并翻译 | 示例
       

摘要

A1 adenosine receptors (A1 receptors) are widely expressed in mammalian tissues; therefore attaining proper tissue selectivity is a cornerstone of drug development. The fact that partial agonists chiefly act on tissues with great receptor reserve can be exploited to achieve an appropriate degree of tissue selectivity. To the best of our knowledge, the A1 receptor reserve has not been yet quantified for the atrial contractility. A1 receptor reserve was determined for the direct negative inotropic effect of three A1 receptor full agonists (NECA, CPA and CHA) in isolated, paced guinea pig left atria, with the use of FSCPX, an irreversible A1 receptor antagonist. FSCPX caused an apparently pure dextral displacement of the concentration-response curves of A1 receptor agonists. Accordingly, the atrial A1 receptor function converging to inotropy showed a considerably great, approximately 80-92 % of receptor reserve for a near maximal (about 91-96 %) effect, which is greater than historical atrial A1 receptor reserve data for any effects other than inotropy. Consequently, the guinea pig atrial contractility is very sensitive to A1 receptor stimulation. Thus, it is worthwhile considering that even partial A1 receptor agonists, given in any indication, might decrease the atrial contractile force, as an undesirable side effect, in humans.
机译:A1腺苷受体(A1受体)在哺乳动物组织中广泛表达;因此,达到适当的组织选择性是药物发育的基石。部分激动剂主要针对具有伟大受体储备组织的组织,可以利用来实现适当程度的组织选择性。据我们所知,A1受体储备尚未为心房收缩合理量化。 A1受体储备是针对孤立的三个A1受体的直接负激动剂(NECA,CPA和CHA)的直接负面疗效,左侧ATRIA,使用FSCPX,一种不可逆A1受体拮抗剂。 FSCPX引起A1受体激动剂浓度反应曲线显然纯的右侧位移。因此,对静脉内的心房A1受体功能会聚有大约80-92%的受体储备对于近乎最大(约91-96%)效应,其大于其他效应的历史心房A1受体储备数据比镜头。因此,豚鼠心房收缩性对A1受体刺激非常敏感。因此,考虑到甚至部分A1受体激动剂在任何指示中均匀,可能会降低心房收缩力,作为人类的不希望的副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号